Skip to content
Jesper Allentoft, Executive Vice President, Stakeholder Relations retires from Chr. Hansen A/S. Ditte Marstrand Wulf appointed as successor.

Press release -

Jesper Allentoft, Executive Vice President, Stakeholder Relations retires from Chr. Hansen A/S. Ditte Marstrand Wulf appointed as successor.

Jesper Allentoft has been with Chr. Hansen since 1 January, 2006 and is now retiring early at the age of 60. Ditte Marstrand Wulf will start as Group Vice President, Stakeholder Relations on 1 August, 2015. She will report to Group CEO Cees de Jong and be part of the Corporate Leadership Team.

“I can’t thank Jesper enough for his contribution to the success of Chr. Hansen,” says CEO Cees de Jong. “Not only has he developed a range of innovative development programs for managers as well as employees, he has also successfully recruited candidates for numerous key positions that are vital for Chr. Hansen. Last, but not least, Jesper’s contribution to the teamwork in the Corporate Leadership Team has been outstanding and he will be sorely missed. However, I wish Jesper a well-deserved, long and happy retirement,” concludes CEO Cees de Jong.

Ditte Marstrand Wulf, age 43, comes from a position as Group HR Director in Codan and Trygg-Hansa and prior to that she was Global Chief People Officer in IC Companys A/S and HR Director for Northern Europe in Microsoft. She holds a M.Sc. in Human Resource Management from Copenhagen Business School of Economics.” I look forward to being a part of the exciting journey that Chr. Hansen has embarked on and to help unlock the company’s full potential through HR, Communications and CSR”, says Ditte Marstrand Wulf.

Cees de Jong comments: “I am very pleased that Ditte is joining us and I look forward to welcoming her to Chr. Hansen in August. I feel confident that she, with her extensive experience, will contribute greatly to our work within Stakeholder Relations and in realizing our strategy, Nature’s No. 1.”

Topics

Categories


Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.

Contacts

Helle Rexen

Helle Rexen

Press contact Media relations officer +45 20 74 28 40
Kathrine Westermann

Kathrine Westermann

Press contact Head of Media Relations +45 23 81 55 95

About us

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.

Chr. Hansen Holding A/S
Boege Allé 10-12
DK-2970 Hoersholm
Denmark